| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 243.60M | — |
| Operating expense | — | — |
| Net income | 25.43M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KNSA returned +134.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +91.6% |
| 1 year | +134.2% |
| 5 years | +528.2% |
| All-time high | $79.03 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KNSA would be worth today ›No. Kiniksa Pharmaceuticals International, plc has not paid a dividend in the past 12 months.
Kiniksa Pharmaceuticals International, plc stock trades on NASDAQ under the ticker symbol KNSA.
Kiniksa Pharmaceuticals International, plc is part of the Healthcare sector.
Kiniksa Pharmaceuticals International, plc has a market cap of 6.17B USD, based on the latest quote.
Kiniksa Pharmaceuticals International, plc is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.
